horus
Junior Member
Posts: 96
|
Post by horus on Dec 12, 2014 23:46:43 GMT
|
|
|
Post by CM kipper007 on Dec 13, 2014 0:31:44 GMT
oh my... Going to read this with a cup of tea!!! Congrats to those who got out.
|
|
|
Post by CM kipper007 on Dec 13, 2014 1:01:28 GMT
Is a no go milestone related to efficacy, or could they just be behind on the trials? It would be a shame for this not to work.
|
|
horus
Junior Member
Posts: 96
|
Post by horus on Dec 13, 2014 1:11:24 GMT
|
|
|
Post by stemwinder on Dec 13, 2014 3:19:28 GMT
supervalueidiot (eigenman) on Twitter recently boasted that he had gone long stem. Couldn't happen to nicer guy.
|
|
|
Post by Keybridge - Cult Member 003 on Dec 13, 2014 3:36:11 GMT
Oh my.
This requires an S.A. article just to make it all better.
|
|
|
Post by CM kipper007 on Dec 13, 2014 3:45:14 GMT
supervalueidiot (eigenman) on Twitter recently boasted that he had gone long stem. Couldn't happen to nicer guy. He's gonna be sweating this weekend if he's short ocat and long stem.
|
|
|
Post by CM kipper007 on Dec 13, 2014 4:13:43 GMT
Think this will affect their price much? They already went under a dollar.
|
|
|
Post by forthefuture on Dec 13, 2014 6:42:52 GMT
CUR and STEM met in court Friday as well I believe. The outcome of that will likely have a bigger impact than the outcome of a preclinical study, even with some loan money attached. It certainly doesn't bode well for STEMs platform though.
|
|
|
Post by JHam on Dec 13, 2014 11:55:02 GMT
Thanks for posting. STEM said on their investor day conference call that Alzheimer's failed and that they would probably be moving on from that indication. So the news about having the $19M loan terminated isn't much of a surprise. That news is probably already figured into the pps since most shareholders have known that that program was dead and buried for a few weeks now. STEM did announce positive news about their AMD trials however, whether people prefer Ocata's results or not. Considering how beaten down this stock is, I can understand why someone would want to buy now instead of later. That's assuming they continue with positive news in the AMD trial.
|
|
|
Post by dayanand33 on Dec 13, 2014 14:11:32 GMT
That's strange because both use the same type of cells. Stem cells can repair/replace the diseased cells. But restoration of erased memory is impossible. Wonder how is Cur meeting with any success.
|
|
|
Post by tmfbmf on Dec 13, 2014 15:33:57 GMT
That's strange because both use the same type of cells. Stem cells can repair/replace the diseased cells. But restoration of erased memory is impossible. Wonder how is Cur meeting with any success. CUR didn't spill their cells on the floor before sticking them in people's heads.
|
|
|
Post by HeyNow on Dec 13, 2014 20:42:10 GMT
Will STEM not be needing to raise money soon? That will be tough to do and stay listed with a current pps of $1. Reverse split perhaps.
|
|
|
Post by Whidbeygal CM 20/20 on Dec 13, 2014 20:54:46 GMT
Will STEM not be needing to raise money soon? That will be tough to do and stay listed with a current pps of $1. Reverse split perhaps. STEM went through a reverse split a couple of years ago. If I remember it was a 10 for 1. Very sorry to hear the Alzheimer's study wasn't a success.
|
|
|
Post by CM kipper007 on Dec 13, 2014 23:58:04 GMT
|
|
|
Post by forthefuture on Dec 15, 2014 22:58:28 GMT
|
|